Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 928 of 5804
-
New combo aims to tame breast cancer with fewer side effects
Disease control CompletedTo verify that combination therapy with trastuzumab + pertuzumab + eribulin brings similar PFS and better QOL compared to trastuzumab + pertuzumab + taxane in advanced/recurrent HER2-positive breast cancer patients who have no medical history of chemotherapy except ado-trastuzuma…
Phase: PHASE3 • Sponsor: Japan Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Precision radiation offers new hope for recurrent prostate cancer
Disease control OngoingThis purpose of this study is to evaluate the safety and effectiveness of a technique called focal high-dose-rate (HDR) brachytherapy as treatment for prostate cancer that has come back in the prostate after prior radiotherapy. The study will examine the safety and efficacy of th…
Phase: NA • Sponsor: Loyola University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New dissolvable stent could revolutionize heart disease treatment
Disease control CompletedThe FUTURE-II study is a confirmative clinical trial for Sirolimus Target Eluting Bioresorbable Vascular Scaffold (Firesorb) after the feasibility and safety of the device has been preliminary confirmed in a small-scale First-in-Man clinical trial.
Phase: NA • Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New epilepsy drug shows promise in reducing partial seizures
Disease control CompletedThe purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in subjects (\>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treatment with 1 or 2 concomitant ant…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could some breast cancer patients skip radiation? major trial seeks answers
Disease control OngoingThis is a randomised, phase III, non-inferiority trial evaluating radiation therapy versus observation following breast conserving surgery and planned endocrine therapy in patients with stage I breast cancer of luminal A subtype defined using the Prosigna (PAM50) Assay.
Phase: NA • Sponsor: Breast Cancer Trials, Australia and New Zealand • Aim: Disease control
Last updated Jun 26, 2026 17:54 UTC
-
Could a common antibiotic and supplement lift bipolar depression?
Symptom relief TerminatedThe purpose of the Pilot Study Investigating the Efficacy of Minocycline and n-acetylcysteine for Bipolar Depression is to test the effectiveness of minocycline, n-acetylcysteine, and combined minocycline and n-acetylcysteine pharmacotherapy in order to fill the gap in treatments…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Can DNA tests pick the right cancer drug for kids?
Knowledge-focused OngoingThis phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard s…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Could a drug combo make food allergy treatment safer?
Disease control CompletedFew studies have been conducted to optimize safety of multiple food allergen oral immunotherapy (OIT) in conjunction with Omalizumab as well as to identify the immunological mechanism(s) underlying any long-lasting effects of OIT. To address these issues in the field of food alle…
Phase: PHASE2 • Sponsor: Andrew Long, PharmD • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New combo slows advanced breast cancer progression
Disease control CompletedThe study is designed to compare the clinical benefit following treatment with aromatase inhibitor in combination with metronomic capecitabine versus aromatase inhibitor alone in women with hormone receptor-positive, Her2-negative advanced breast cancer who have not received prio…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Ohio study aims to beat lung cancer with smarter testing
Knowledge-focused Recruiting nowThis randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer in Ohio protocol may help in evaluating immunotherapies and targeted therapies that prolong survival…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New radiation method aims to protect scalp in brain tumor patients
Disease control OngoingThis phase II trial studies how well intensity-modulated stereotactic radiation therapy works in treating patients with grade II-IV glioma. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may ca…
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Which works best for stubborn depression? adding a drug, brain stimulation, or switching meds?
Disease control CompletedThis is a multi-site, randomized, open-label, effectiveness trial comparing three treatment arms for Major Depressive Disorder (MDD) patients with TRD who are currently on ongoing, stable and adequate antidepressant therapy (ADT). Adequate ADT is defined as a therapeutically suff…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for advanced prostate cancer: palbociclib trial shows promise
Disease control OngoingThe purpose of this study is to find out what effects a new drug, palbociclib, has on prostate cancer and will look at the side effects of treatment with palbociclib. The researchers doing this study are also interested in looking for markers that may help predict which patients …
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo vaccine for infants shows promise in small trial
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to evaluate the safety and efficacy of an intramuscular injection of BK1310 in healthy infants.
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Could treating sleep apnea during a COPD hospital stay keep patients out of the hospital?
Disease control TerminatedThe purpose of this study is to determine whether early diagnosis of OSA and initiation of and adherence to CPAP therapy in patients hospitalized for chronic obstructive pulmonary disease reduce 30-day hospital readmission rates.
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Pancreatic surgery showdown: which drug prevents leaks best?
Disease control CompletedThe purpose of this study is to determine whether somatostatin is more effective that octreotide in the prevention of post-pancreatectomy pancreatic fistula
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 15:47 UTC
-
Mind over muscle: new device helps stroke survivors move again
Symptom relief CompletedThis study aims to evaluate the impact of the Neurolutions Upper Extremity Rehabilitation System, known as IpsiHand, on improving functional motor control for post-stroke patients with hemiparesis. The Neurolutions System is a brain-computer interface (BCI) comprised of a robotic…
Phase: NA • Sponsor: Neurolutions, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
In-Clinic polyp removal could replace costly sinus surgery
Symptom relief Recruiting nowChronic rhinosinusitis, also called chronic sinusitis, is a very common life-long disease affecting over 5% of the Canadian population. Its symptoms, including daily facial pain and headache, an inability to breath through the nose and complete smell loss, regularly impair one's …
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Vitamin d levels after heart attack: a simple fix for major risks?
Disease control CompletedThis study evaluates whether achieving 25-hydroxyvitamin D (25\[OH\] Vit D) levels (\>40 ng/mL) among myocardial infarction patients will result in a reduction of cardiovascular-related adverse events. Half of the patients will be randomized to receive standard of care and half w…
Phase: PHASE4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New artificial disc could replace fusion for neck pain sufferers
Disease control CompletedThis study is intended to demonstrate that the Simplify® Cervical Artificial Disc (Simplify® Disc) is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) when used to treat two contiguous discs from C3 to C7 following discectomy at two co…
Phase: NA • Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC